Argenta Technologies
Differentiate your product with a proven, licensable platform
Get to market faster with a validated, patent-protected drug delivery technology developed exclusively for veterinary use. License one of our three platforms for your molecule, with development, manufacturing, and regulatory support from the same team.
Talk to our formulation scientists
Up to 34% drug loading in our microspheres
343 days of controlled release from a single capsule
>85% full acceptability for our soft chews
Our Technologies

Reduce dosing frequency with biodegradable lipid microspheres that release your API over one week to 12 months. They’re small enough for standard syringe injection, and they mask bitter flavours in oral formulations.

Treat cattle and sheep for up to a year from a single administration, with zero-order release proven over 343 days and multiple APIs delivered from one device.

Give pets a dose they’ll take, with >85% full acceptability. Continuous low-temperature extrusion with no added water delivers tablet-level stability in a treat-like format for pharmaceutical and nutraceutical products.
Integrate your molecule with a platform that’s already validated, so you avoid the time and cost of developing a new dosage form in-house.


Fewer doses, better palatability, and simpler administration make treatment more reliable for pets, livestock, and the people caring for them.
Reformulate an existing molecule on a patent-protected platform to differentiate it and protect its place in the market.

Check compatibility, release profile options, and formulation strategy before you make a significant investment.
Optimise the platform for your API, target species, and therapeutic goals.
Compile your dossier with our in-house animal health regulatory team.
Manufacture at commercial scale in our GMP facilities.

.webp)
